Design, antiproliferative potency, and in silico studies of novel 5-methylfuran-3-yl)thio)-3-phenylquinazolin-4(3H)-one based derivatives as potential EGFR inhibitors by Sara M. Soliman, Adel A.-H. Abdel-Rahman, Eman S. Nossier, Modather F. Hussein, Amr Sabry, Hagar S. El-Hema

Get full text

PI3K Inhibitors of Novel Hydrazide Analogues Linked 2-Pyridinyl Quinazolone Scaffold as Anticancer Agents by Ibrahim F. Zeid, Neama A. Mohamed, Nagy M. Khalifa, Emad M. Kassem, Eman S. Nossier, Ahmed A. Salman, Khaled Mahmoud, Mohamed A. Al-Omar

Get full text

Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity by Adel A.-H. Abdel-Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, Eman M. El-Ganzoury, Eman S. Nossier, Hanem M. Awad, Wael A. El-Sayed

Get full text

Design, Characterization, Antimicrobial Activity, and In Silico Studies of Theinothiazoloquinazoline Derivatives Bearing Thiazinone, Tetrazole, and Triazole Moieties by Hagar S. El-Hema, Sara. M. Soliman, Wagdy El-Dougdoug, Mohamed H. M. Ahmed, Abdelmotaal Abdelmajeid, Eman S. Nossier, Modather F. Hussein, Ashtar A. Alrayes, Mariam Hassan, Noha A. Ahmed, Amr Sabry, Adel A.-H. Abdel-Rahman

Get full text